Response to tigilanol tiglate in dogs with mast cell tumors
Tigilanol tiglate is an effective local treatment option for mast cell tumors in dogs with a predictable clinical course and response. Because of the unique mode of action and clinical course, client education and careful case selection is necessary before electing tigilanol tiglate for local treatment.
Authors
- Margaret Musser (ORCID: https://orcid.org/0000-0003-4350-0614)
- Theodore G. Goodson III (ORCID: https://orcid.org/0000-0003-2453-2290)
- Pamela D. Jones (ORCID: https://orcid.org/0000-0003-3107-1584)
- Chad M. Johannes (ORCID: https://orcid.org/0000-0003-1855-6966)
- Erin Roof
Institutions
- Iowa State University (US)
- Queensland Government (AU)
- Cleveland Clinic Florida (US)
- Neurology Associates (US)
- Colorado State University (US)
Publication Details
- Journal
- Journal of Veterinary Internal Medicine
- Published
- 2024-10-17
- DOI
- https://doi.org/10.1111/jvim.17211
- Citations
- 2
- Primary Topic
- Veterinary Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.84
Funders
- Iowa State University
- Qbiotics